环氧合酶抑制剂对保乳根治术患者瑞芬太尼输注引起痛觉
超敏的影响

您当前的位置：

首页 >

文章列表页 >

环氧合酶抑制剂对保乳根治术患者瑞芬太尼输注引起痛觉超敏的影响

更新时间：2023-12-12

- 环氧合酶抑制剂对保乳根治术患者瑞芬太尼输注引起痛觉超敏的影响
- Effects of COX Inhibition on Hyperalgesia Inducing by Remifentanil Infusion after Mastectomy
- 中山大学学报（医学科学版） 2016年37卷第3期
- 作者机构：
- 作者简介：
- 基金信息：
  
  国家自然科学基金面上项目(30772091)
- DOI：
  中图分类号：
- 网络首发：2016-05-20，
  
  纸质出版：2016
- 稿件说明：
移动端阅览
环氧合酶抑制剂对保乳根治术患者瑞芬太尼输注引起痛觉超敏的影响[J]. 中山大学学报（医学科学版）, 2016,37(3).

Effects of COX Inhibition on Hyperalgesia Inducing by Remifentanil Infusion after Mastectomy[J]. Journal of Sun Yat-sen University (Medical Sciences), 2016, 37(3).
环氧合酶抑制剂对保乳根治术患者瑞芬太尼输注引起痛觉超敏的影响[J]. 中山大学学报（医学科学版）, 2016,37(3). DOI：

Effects of COX Inhibition on Hyperalgesia Inducing by Remifentanil Infusion after Mastectomy[J]. Journal of Sun Yat-sen University (Medical Sciences), 2016, 37(3). DOI：

摘要

摘要: 【目的】观察环氧合酶-1抑制剂和环氧合酶-2抑制剂能否防治乳腺癌保乳根治术患者瑞芬太尼持续输注引起的痛觉超敏?【方法】选择年龄在30~65岁之间ASAⅠ~Ⅱ级择期在全麻下行单侧乳腺癌保乳根治术的女性患者64例为研究对象

按照预处理的不同随机分为完全空白对照组(C组)

瑞芬太尼组(R组)

COX-2抑制剂帕瑞昔布+瑞芬太尼组(PR组)

COX-1抑制剂酮咯酸+瑞芬太尼组(KR组)

每组各16例?C组患者手术全程输注等容量外观的生理盐水;R组患者在瑞芬太尼开始泵注前15 min静脉注射同等容量和外观的生理盐水;PR组患者在瑞芬太尼开始泵注前15 min静脉注射40 mg帕瑞昔布钠;KR组患者在瑞芬太尼开始泵注前15 min静脉注射30 mg 酮咯酸?观察指标包括拔管后5 min(VAS1)?15 min(VAS2)?30 min(VAS3)?60 min(VAS4)的视觉模拟评分(VAS评分)

拔管后追加补偿镇痛的剂量和次数?【结果】 ① R组VAS1评分显著高于PR组?KR组和C组(P值分别为 P < 0.001

P = 0.035

P = 0.020);R组VAS2评分显著高于PR组和KR组(P值分别为 P = 0.001

P = 0.024)?各组间VAS3和VAS4评分不存在统计学差异?②PR组在VAS1评分时点需要追加补偿镇痛的人次少于R组和KR组(P值分别为P = 0.001

P = 0.023)

在VAS2评分时点需要追加补偿镇痛的人次少于R组(P = 0.007);在VAS3和VAS4评分时点需要追加补偿镇痛的人次各组间不存在统计学差异? 【结论】 ①单侧乳腺癌保乳根治术患者持续输注瑞芬太尼能够引起痛觉超敏?②帕瑞昔布及酮咯酸预处理可减少瑞芬太尼持续输注引起的痛觉超敏?③帕瑞昔布组术后需要追加镇痛的患者明显少于酮咯酸组和瑞芬太尼组

提示COX-2抑制剂降低痛觉超敏的作用可能比COX-1的抑制剂更强?

Abstract

Abstract:【Objective】 To investigate the effects of COX -2 (parecoxib) and COX -1 (ketorolac) inhibition on hyperalgesia

which was induced by remifentanil infusion in patients after mastectomy. 【Methods】 A total of 64 patients (aged 30 -65

ASAⅠ -Ⅱ) undergoing selective protective and radical operation of mastocarcinoma were enrolled in this study. The patients were equally divided into four groups in random. There were 16 patients in each group (Group C

Group R

Group PR

and Group KR). Patients in group C and group R were given an equal volume of NS (0.9% NaCl Saline NS). And patients in group C did not receive remifentanil infusion during the whole surgery procedure. For patients in group PR

Parecoxib 40 mg were administrated as pretreatment by intravenous injection before remifentanil infusion

while 30 mg Ketorolac for the patients in group KR. The degree of patients’ postoperative pain after extubation was evaluated at four time spots (using VAS score). The dose and frequency of analgesic drugs supplement were observed and recorded. 【Results】 ①The VAS1 score in group R is remarkably higher than that in group C

group PR and KR (P = 0.020

P < 0.001

P = 0.035). The VAS2 score in group is statistically higher than that of group PR and KR (P = 0.001

P = 0.024). The VAS3 and VAS4 scores among the four groups were not statistically different. ②The need of analgesics in group PR at VAS1 was remarkably less than that in group R and KR (P = 0.001

P = 0.023). And the need of analgesics in group PR at VAS2 was remarkably less than that in Group R (P = 0.007). The need for analgesics among four groups at VAS3 and VAS4 were not statistically significant. 【Conclusion】①Infusion of Remifentanil during mastectomy can elicit pain sensitivity owing to opioid -induced hyperalgesia (OIH). ②Pretreatment with parecoxib or ketorolac can attenuate OIH in some extent. ③Compared with Group KR

the patients in Group PR needed less supplementary analgesics. Therefore COX-2 in-hibition is much better than COX-1 inhibition in reducing hyperalgesia.

关键词

Keywords

references

浏览量

229

下载量

CSCD

文章被引用时，请邮件提醒。

提交

工具集

关联资源

伊伐布雷定抑制瑞芬太尼诱导的小鼠痛觉过敏

瑞芬太尼下调大鼠背根神经节和脊髓背角GIRK2的表达

脊髓CCL2在瑞芬太尼诱导的大鼠痛觉过敏中的作用机制

活性氧激活的脊髓星形胶质细胞参与瑞芬太尼诱发的痛觉过敏